Dossier out-licensing services
Unlock New Markets and Ensure Sustainable Growth in Pharmaceuticals with Our Future-Focused Out-licensing Solutions
Unlock New Markets and Ensure Sustainable Growth in Pharmaceuticals with Our Future-Focused Out-licensing Solutions
We provide comprehensive preparation, market analysis, regulatory compliance, and on-going support for partners to successfully commercialize products in new markets through seamless transfer of documentation and knowledge.
Out-licensing services involve granting another organization the rights to a pharmaceutical product’s regulatory dossier for commercialization in defined markets. This process requires structured documentation, data integrity, and alignment with internationally accepted regulatory frameworks and good documentation practices. Zenovel provides specialized dossier out-licensing services to help companies maximize product value by enabling efficient transfer of regulatory knowledge, supporting compliant dossier handover, and facilitating the identification of suitable strategic partners.
Through Out-licensing, we can enable your products to attain their maximum potential and contribute to global well-being. We, therefore assist you to search for complimentary, win-win alliances while keeping an eye on the future.
We help identify complementary, win-win alliances, form strategic partnerships for growth, and monitor future opportunities.
We develop tailored strategies to meet the unique needs of your target market, ensuring your dossier adheres to all necessary compliance standards.
We ensure a smooth transfer of your dossier to the licensee and provide continuous support to ensure successful post-transfer and effective commercialization.
India is a significant player in the global pharmaceuticals sector, characterized by a diverse population and cost-effective infrastructure. However, its potential in clinical research is hindered by complex regulatory challenges that delay innovations and deter investment, affecting the timely market introduction of life-saving drugs. This blog discusses the major obstacles
The FDA issued 466 Form 483s to drug organizations in FY 2022, more than double the previous year, highlighting significant quality failures in the pharmaceutical sector. For startups and scale-ups seeking market approval, the excitement of innovation often conflicts with the strict requirements of current good manufacturing practices (cGMP). Although
In the pharmaceutical and biotechnology industries, obtaining regulatory approval is essential prior to introducing new drugs or biologics to the market. A pivotal aspect of this approval process is the FDA Pre-Approval Inspection (PAI), which involves a comprehensive assessment of manufacturing facilities, processes, and data integrity to ensure adherence to
Risk Based Monitoring (RBM) is a more efficient alternative to traditional clinical trials, focusing on high-risk areas through data-driven insights. It ensures patient safety, data integrity, and regulatory compliance while reducing costs and timelines. However, the success of RBM depends on the competency of monitors, who identify risks, analyze data,
Welcome to the Zenovel Blog! We are a leading provider of drug regulatory consulting and education, focusing on advancing pharmaceutical innovation while ensuring safety and compliance. This blog delves into the essentials of Drug Regulatory Affairs (DRA), covering its scope, career opportunities, and intricate processes involved in bringing new drugs
The international pharmaceutical landscape is inherently connected to the global economy and global trade, which is consisted with the quality and safety assurance , well-controlled quality and safety. Compliance with international pharmaceutical standards has changed from an optional step to a requirement. The Pharmaceutical Inspection Co-operation Scheme (PIC/S Certification) is
We provide affordable, innovative, and high-quality solutions to pharma industry with ethics driven research and increasing accessibility to high quality medicine worldwide
Copyright © 2024 Zenovel. All rights reserved.